borderline significantP = 0.051
The effect of ER-APAP in reducing pain intensity (measured as change from baseline) was significantly greater than that of placebo ( P = 0.004) and borderline significant compared with no treatment ( P = 0.051).
The effect of ER-APAP in reducing pain intensity (measured as change from baseline) was significantly greater than that of placebo ( P = 0.004) and borderline significant compared with no treatment ( P = 0.051).